Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. - Wikidata - wikimedia - TriplyDB

Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.

Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.

http://www.wikidata.org/entity/Q33849500

about

Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions Metastatic mechanisms in follicular cell-derived thyroid cancer High IL-17 expression is associated with an unfavorable prognosis in thyroid cancer Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.Immune response in thyroid cancer: widening the boundaries.MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier.The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays.The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer The distribution of cutaneous metastases correlates with local immunologic milieu Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer The immune network in thyroid cancer HPV infection: immunological aspects and their utility in future therapy Targeting thyroid cancer microenvironment: basic research and clinical applications.Changes of regulatory T and B cells in patients with papillary thyroid carcinoma after 131I radioablation: a preliminary study Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7.Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.Influence of human immune cells on cancer: studies at the University of Colorado.Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.Molecular pathways associated with aggressiveness of papillary thyroid cancer Study of the histological profile of papillary thyroid carcinomas associated with Hashimoto's thyroiditis.A new strategy for the surgical management of RLN infiltrated by well-differentiated thyroid carcinoma.Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma.Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.Association between FOXP3 gene polymorphisms and risk of differentiated thyroid cancer in Chinese Han population.Novel targeted therapies and immunotherapy for advanced thyroid cancers.Thyroid-Specific T Cells in Patients With Differentiated Thyroid Cancer: Implications for Immune-Based Therapies?Differentiated thyroid carcinomas and their B7H1 shield.The role of IgG4 (+) plasma cells in the association of Hashimoto's thyroiditis with papillary carcinoma.Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers Functional Foxp3 polymorphisms and the susceptibility to cancer: An update meta-analysis

P2860

Q26863326-D8448634-C4D0-46C3-A049-65D3FB9DA612 Q27005646-9BFC4665-00BA-4933-BCE4-AB63A8F7DEB7 Q33597831-05EEF52C-C8DB-4150-A945-E0E672A4B806 Q33848273-AE7B9BE0-5F20-4D78-9720-B529CA6E3071 Q34103836-A716A08D-7F1D-458A-87DD-DDED1C35BD11 Q34310495-AA98F706-F9CA-42F5-AFFC-705464AB7854 Q34615021-97F22F12-8EB5-4D67-8840-B9E02CE9B2F4 Q34975148-C5C22D3E-FA8D-4976-A7A6-5E6C8D385C6B Q34996501-0B7D9545-6564-40CF-BC57-D7614AE5338F Q35931795-9861C65F-A19A-498E-94A6-314C4042124B Q35956309-21EDEEBF-2EAA-4CE5-A9AD-F5D0DAC8BB3D Q36069862-C5EFD1BD-F078-4993-84B5-472E7FBF1E48 Q36600183-7A2A95D3-FE1F-403C-B62B-43F898F0B256 Q37057942-08367F6A-1B2D-47A6-8519-DEAFE5E2482B Q37079138-F7E75EC4-4B61-4543-85B3-CDD8C6896267 Q37145093-F6134877-977B-43F5-8D9E-AA1F59031602 Q37275748-F7BDD631-48A7-4956-8E3C-1FDD776DAE85 Q37375644-711F26A5-C314-48D0-8439-C0AB3D65444E Q37398442-D64474DD-9452-462D-8367-8A623D3A0C7A Q37442008-EFB5357E-6AB9-4F19-B431-406D3A60CE42 Q37698684-330E9AB7-7D69-41A4-A343-14F2C08DC6B6 Q38385286-A87C1432-A040-423C-8E9B-CB75D22576EB Q39171721-6FE668FC-6AE2-4E06-B864-BBB529A69C9D Q39351408-9EEE935B-B1EE-4B98-82E6-B7A629959482 Q40556671-34386223-54A2-4480-AB79-C91DEA793730 Q44175989-9878487D-DCF2-46FB-8145-B7264AEFC449 Q44985713-FFABBFD7-9D5C-4641-909D-ED055C01AB9F Q45780286-B284D634-C837-44C5-94E4-C4A785EED9F4 Q46829537-F1E8AB46-3341-4797-AC09-A16F860D207B Q47325812-45F2EECD-1DD2-432E-8C5C-F45611797AE1 Q47933437-C533157D-451C-41FC-915A-8D4675488A8B Q49887965-002401B3-C80F-4A52-AAB6-A16988632510 Q50130422-F17EE024-76B1-439F-A8A9-80E425F1BEA1 Q51013874-B69CFCB9-60A3-4F13-89A2-CEBDA9C5E333 Q53232392-FFA8862E-FA30-4E19-9778-E5D2AF65D217 Q55497094-B3CACFEB-C58A-434C-BDB2-1E63FB9D44BD Q56891239-EC077893-C34E-4E75-B19B-2442274DA3FA Q58706290-BBC40231-6CE4-4A40-89A3-A2B6942E236F

P2860

Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.

http://www.wikidata.org/entity/Q33849500

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Tumor-associated lymphocytes a ...... sive papillary thyroid cancer.

@ast

Tumor-associated lymphocytes a ...... sive papillary thyroid cancer.

@en

type

label

Tumor-associated lymphocytes a ...... sive papillary thyroid cancer.

@ast

Tumor-associated lymphocytes a ...... sive papillary thyroid cancer.

@en

prefLabel

Tumor-associated lymphocytes a ...... sive papillary thyroid cancer.

@ast

Tumor-associated lymphocytes a ...... sive papillary thyroid cancer.

@en

P1433

Q33849500-D2F7A7F5-3464-45E6-A567-1035CFF8C3C2

P1476

Q33849500-3793DE55-732D-4CAE-8EAD-B0CE559DECE1

P2093

Q33849500-367873A6-DA70-4F4D-8059-56519DD1356B

Q33849500-5AB0E3DD-E720-4153-B6EB-4C7A13191CFA

Q33849500-61431AAC-FD32-4590-AC7E-873EA054BB61

Q33849500-65A6935B-9F53-4C73-A916-7FCBFC54CB43

Q33849500-AE21A7E6-E49B-48A9-8B9B-C3FAA03BF876

Q33849500-CFAC678F-8A2F-47BF-87AD-C4BC7C54ECCD

P2860

Q33849500-0CCED2A4-B725-4C99-9377-24928F0AE887

Q33849500-12404F77-42A1-4BD2-9C9D-CFA17AE9AF8E

Q33849500-184ACED2-0F33-428C-9C36-7AD12CF7FC1A

Q33849500-1ADEECFD-FF38-446E-AC4D-FA09FAFE39A0

Q33849500-1B4E1598-AF24-4B61-909E-EEC2FC4EF47F

Q33849500-21678790-6EAA-4DC9-BE57-3DFD2D1FF559

Q33849500-28616A2F-E7BF-4DE7-A9BC-968A07CA8362

Q33849500-3F828650-3500-46FF-B8EE-79D7361BD81D

Q33849500-4177CD4F-5794-4424-BAC9-95629FBF220B

Q33849500-456B40DC-0098-4AC2-A4D2-FC23954B83A2

P304

Q33849500-3373D152-8A94-4540-A408-F61AA950300F

P31

Q33849500-7B952CC4-FEB3-4EDE-9C5A-D91F4294B9C8

P356

Q33849500-F6584EF8-E1DD-437A-B5F3-634398FA1F2E

P407

Q33849500-E6921BDB-BBDD-4CC1-8543-F2E6C1716CEB

P433

Q33849500-A71611A1-8C1C-42E7-B73B-2FCBA4D0ECA2

P478

Q33849500-FAC5F43A-5022-474E-99FC-B9789E2B580C

P577

Q33849500-C0F1FA8C-FF50-41E2-AC7A-6C6A9A0DB089

P698

Q33849500-B4A2A1C6-B0FE-48FA-B665-96767737CAD0

P932

Q33849500-05535881-B0B4-438F-852E-F0CD08BC1217

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Tumor-associated lymphocytes a ...... sive papillary thyroid cancer.

@en

P2093

Bryan R Haugen

http://www.w3.org/2001/XMLSchema#string

Deborah L Fretwell

http://www.w3.org/2001/XMLSchema#string

Jena D French

http://www.w3.org/2001/XMLSchema#string

Joshua P Klopper

http://www.w3.org/2001/XMLSchema#string

Sherif Said

http://www.w3.org/2001/XMLSchema#string

Zachary J Weber

http://www.w3.org/2001/XMLSchema#string

P2860

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer

The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases.

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

CD4 T cells: fates, functions, and faults

Natural versus adaptive regulatory T cells.

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Antigen-induced regulatory T cells.

Mechanisms and functional significance of tumour-induced dendritic-cell defects.

P304

2325-2333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2009-2564

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20207826

http://www.w3.org/2001/XMLSchema#string

P932

2869546

http://www.w3.org/2001/XMLSchema#string